Poster uttalelsen fra Prof. De Meirleir her også:
«The contamination by mouse material was excluded in our study, that of Lo and that of Lombardi et al. We are not using PCR as a basis of the test but human prostate cancer cells that do not express RNase L so the virus from patient’s blood can grow in it. We also sequence the virus and I can assure you it is not mouse material.
Governments and insurance companies are horrified by the idea that there is a new retrovirus out there that has infected 10 times more people than HIV up to date. My preliminary data show that the virus does not grow in culture anymore after Nexavir + GcMAF although the procedure was identical to the pretreatment culture.
In the next months more will come from our side. A study with healthy blood donors, ME patients who got ill immediately after blood transfusion and ME patients who gave blood after they got ill will be published in the first half of 2011.
What these 5 are doing to the patients is a crime against humanity.
Kenny De Meirleir”
Har dessverre ingen link da dette er hentet fra direkte korrespondanse.
Hentet fra WPIinstitute.org:
«These scientific findings cannot be explained by contamination with mouse cells, mouse DNA or XMRV-related virus-contaminated human tumor cells. No mouse cell lines and none of the human cell lines reported today by Hue et al. to contain XMRV were ever cultured in the WPI lab where our PCR experiments were performed. Humans cannot make antibodies to viruses related to murine leukemia viruses unless they have been exposed to virus proteins. Therefore, recent publications regarding PCR contamination do not change the conclusions of the Lombardi et al. and Lo et al. studies that concluded that patients with ME/CFS are infected with human gammaretroviruses.»
Les hele uttalelsen HER
Privat mail fra Ian Lipkins hentet her
«These papers emphasize the pitfalls of molecular assays and raise concerns. Nonetheless, it is premature to rule out XMRV or related viruses as factors in prostate cancer or CFS. Links have also been made based on serology and the presence of viral proteins as well as of viral sequences. Thus, we still need appropriately powered, rigorous blinded studies of well characterized patients and controls. One such study is underway under the auspices of the National Institutes Health.
W. Ian Lipkin, MD
John Snow Professor of Epidemiology and Director
Center for Infection and Immunity
Mailman School of Public Health
Professor of Pathology and Neurology
College of Physicians & Surgeons
722 West 168th Street, 17th Floor
«Det er fremsatt mistanke om at all funn av XMRV er kun forurensning ifra mus. For mere informasjon om dette, se her
Vi på Lillestrøm helseklinikk ønsker overhode ikke å avviseXMRV funnene inntil mere forskning foreligger. Vi har tillit til forskerne bak Science artikkelen fra oktober 2009, som ivaretok alle forhåndsregler for å unngå kontaminering. Om andre studier i ettertid har unngått kontaminering kan vi ikke ta stilling til.
Vi har tiltro til at våre samarbeidende forskere på Whittemore-Peterson-Instituttet og San Raffaele Scientific Institute ivaretar spørsmålet om kontaminering i forskningen som pågår.
Vi ønsker å vise til historien omkring funnet av HIV. Dengang tok det 2 år før viruset ble “allment akseptert” av forskningsmiljøet. Vi erfarer at det er idag større tendenser til å motbevise, enn å samarbeide. Vi håper det ikke vil bli like probematisk for mulig smittede pasienter idag som det var for positive HIV pasienter dengang.
For kommentaren ifra WPI, se her»
Artikkel i Wall Street Journal:
«The papers focus on various problems associated with a specific kind of test used to detect XMRV but does not examine every method used to detect XMRV. Smith pointed out that some of the previous papers on prostate cancer found XMRV integrated into the patients’ DNA and ”I can’t come up with a mechanism where there would be contamination there.”
Judy Mikovits, who led the team of researchers that published the link between CFS and XMRV in Science last year, said her team was able to culture XMRV from the patients’ blood and show antibody responses indicating they had been exposed to XMRV at some point. ”You will not make an immune response to a lab contaminant,” she told Health Blog.
Dr. Coffin said the debate over XMRV will continue. ”This is not the end of XMRV,” Coffin said, ”but it is a warning we have to be very, very careful.”»
Les hele artikkelen HER
Blogginnlegg fra CFS Patient Advocate:
«One thing is assured. This struggle will continue – and please imagine the bad guys losing. Think of what it would really be like if the ME/CFS community had to rely on these suckers – Coffin, Stoye, Huber, whatshername – to do anything for us. We would be finished.»
Les hele blogginnlegget HER
blogginnlegg fra Marias Metode:
«Slik det ser ut nå er dette en studie som bekrefter at man ikke kan stole på prøvemetoden, PCR og at man må fortsette å bruke testing på cultur og serologi, som er ulike måter å teste blodet på.»
Les hele innlegget HER